{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:00:06Z","timestamp":1790964006199,"version":"4.1.0"},"reference-count":31,"publisher":"Bioscientifica","issue":"1","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In order to evaluate the link between primary hyperparathyroidism (pHPT) and malignancies, cases subjected to parathyroid adenomectomy (PTX) during 1958\u20131997 in Sweden were identified by analyzing the National Swedish Cancer Registry. To minimize the influence of confounding by detection, cases with malignant disease diagnosed before or at the same time as pHPT or during the first year after PTX were excluded. Altogether 9782 cases (7642\u2640) were included and followed for up to 40 years. Thus, the study comprises 89 571 person-years of observation. The incidence of malignancies was compared with that in the Swedish population standardized for age, sex, and calendar year. An increased overall incidence of cancer was demonstrated in both genders (standardized incidence ratio (SIR) 1.43, 95% confidence interval (CI) 1.35\u20131.52). This remain unchanged beyond 15 years after PTX. Breast cancer contributed a quarter of the cancer incidence in women (SIR 1.44, 95% CI 1.25\u20131.62). An increased risk of kidney (SIR 2.40, 95% CI 1.72\u20133.25), colonic (SIR 1.46, 95% CI 1.19\u20131.77), and squamous cell skin cancer (SIR 2.79, 95% CI 2.25\u20133.43) was found in both genders. The risk of endocrine and pancreas cancer was increased in the minority of patients who had their PTX before the age of 40. We conclude that pHPT is associated with an increased risk of developing malignancies that persists even after PTX. This suggests a causal disassociation with the biochemical derangements caused by parathyroid adenoma, while potentially common etiological mechanisms may include genetic predisposition or acquired disability to withstand environmental influence.<\/jats:p>","DOI":"10.1677\/erc.1.01261","type":"journal-article","created":{"date-parts":[[2007,3,29]],"date-time":"2007-03-29T19:19:02Z","timestamp":1175195942000},"page":"135-140","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":61,"title":["The association between primary hyperparathyroidism and malignancy: nationwide cohort analysis on cancer incidence after parathyroidectomy"],"prefix":"10.1530","volume":"14","author":[{"given":"Inga-Lena","family":"Nilsson","sequence":"first","affiliation":[{"name":"Department of Surgery, Karolinska University Hospital, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zedenius","sequence":"additional","affiliation":[{"name":"Department of Surgery, Karolinska University Hospital, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yin","sequence":"additional","affiliation":[{"name":"1Epidemiology Unit, Department of Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ekbom","sequence":"additional","affiliation":[{"name":"1Epidemiology Unit, Department of Medicine, Karolinska University Hospital, SE-171 76 Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070905575550700_BACKLUND-ETAL-2005","unstructured":"Backlund\n            LM\n          , Grander D, Brandt L, Hall P & Ekbom A 2005 Parathyroid adenoma and primary CNS tumors. International Journal of Cancer113866\u2013869."},{"key":"2026070905575550700_BERGENFELZ-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Bergenfelz\n            A\n          , Lindblom P, Lindergard B, Valdemarsson S & Westerdahl J 2003 Preoperative normal level of parathyroid hormone signifies an early and mild form of primary hyperparathyroidism. World Journal of Surgery27481\u2013485.","DOI":"10.1007\/s00268-002-6649-1"},{"key":"2026070905575550700_BIANCHINI-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Bianchini\n            F\n          , Kaaks R & Vainio H 2002 Overweight, obesity and cancer risk. Lancet Oncology3565\u2013574.","DOI":"10.1016\/S1470-2045(02)00849-5"},{"key":"2026070905575550700_BIKLE-ETAL-2005","unstructured":"Bikle\n            DD\n          , Oda Y & Xie Z 2005 Vitamin D and skin cancer: a problem in gene regulation. Journal of Steroid Biochemistry and Molecular Biology9783\u201391."},{"key":"2026070905575550700_BOLLAND-ETAL-2004","unstructured":"Bolland\n            MJ\n          , Grey AB, Gamble GD & Reid IR 2004 Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism901525\u20131530."},{"key":"2026070905575550700_BRESLOW-AND-DAY-1987","unstructured":"Breslow\n            NE\n           & Day N 1987Statistical Methods in Cancer Research. Lyon: IARC Scientific Publications 82."},{"key":"2026070905575550700_CARLING-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Carling\n            T\n          , Rastad J, Akerstrom G & Westin G 1998 Vitamin D receptor (VDR) and parathyroid hormone messenger ribonucleic acid levels correspond to polymorphic VDR alleles in human parathyroid tumors. Journal of Clinical Endocrinology and Metabolism832255\u20132259.","DOI":"10.1210\/jc.83.7.2255"},{"key":"2026070905575550700_CARLING-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Carling\n            T\n          , Rastad J, Szabo E, Westin G & Akerstrom G 2000 Reduced parathyroid vitamin D receptor messenger ribonucleic acid levels in primary and secondary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism852000\u20132003.","DOI":"10.1210\/jcem.85.5.6607"},{"key":"2026070905575550700_CHEN-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Chen\n            JD\n          , Morrison C, Zhang C, Kahnoski K, Carpten JD & Teh BT 2003 Hyperparathyroidism-jaw tumour syndrome. Journal of Internal Medicine253634\u2013642.","DOI":"10.1046\/j.1365-2796.2003.01168.x"},{"key":"2026070905575550700_DENT-AND-WATSON-1964","unstructured":"Dent\n            CE\n           & Watson LCA 1964 Hyperparathyroidism and cancer. British Medical Journal2218\u2013221."},{"key":"2026070905575550700_FIERABRACCI-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Fierabracci\n            P\n          , Pinchera A, Miccoli P, Conte PF, Vignali E, Zaccagnini M, Marcocci C & Giani C 2001 Increased prevalence of primary hyperparathyroidism in treated breast cancer. Journal of Endocrinological Investigation24315\u2013320.","DOI":"10.1007\/BF03343867"},{"key":"2026070905575550700_GIOVANNUCCI-2005","doi-asserted-by":"crossref","unstructured":"Giovannucci\n            E\n          \n          2005 The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control1683\u201395.","DOI":"10.1007\/s10552-004-1661-4"},{"key":"2026070905575550700_HAGSTROM-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Hagstrom\n            E\n          , Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P & Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clinical Endocrinology56253\u2013260.","DOI":"10.1046\/j.0300-0664.2001.01468.x"},{"key":"2026070905575550700_HEDBACK-AND-ODEN-2003","doi-asserted-by":"crossref","unstructured":"Hedback\n            G\n           & Oden A 2003 Recurrence of hyperparathyroidism; a long-term follow-up after surgery for primary hyperparathyroidism. European Journal of Endocrinology148413\u2013421.","DOI":"10.1530\/eje.0.1480413"},{"key":"2026070905575550700_HEDBACK-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Hedback\n            G\n          , Tisell LE, Bengtsson BA\u030a, Hedman I & Oden A 1990 Premature death in patients operated on for primary hyperparathyroidism. World Journal of Surgery14829\u2013836.","DOI":"10.1007\/BF01670531"},{"key":"2026070905575550700_HEDBACK-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Hedback\n            G\n          , Oden A & Tisell LE 1995 Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery117134\u2013139.","DOI":"10.1016\/S0039-6060(05)80076-5"},{"key":"2026070905575550700_HICKEY-ETAL-1991","unstructured":"Hickey\n            RC\n          , Jung PJ, Merrel R, Ordonez N & Samaan NA 1991 Parathyroid adenoma in a cancer center population. American Journal of Surgery161439\u2013442."},{"key":"2026070905575550700_KATZ-ETAL-1970","unstructured":"Katz\n            A\n          , Kaplan L, Massry SG, Heller R, Plotkin D & Knight I 1970 Primary hyperparathyroidism in patients with breast carcinoma. Archives of Surgery101582\u2013585."},{"key":"2026070905575550700_KOCH-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Koch\n            CA\n          , Huang SC, Moley JF, Azumi N, Chrousos GP, Gagel RF, Zhuang Z, Pacak K & Vortmeyer AO 2001 Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma. Oncogene207809\u20137811.","DOI":"10.1038\/sj.onc.1204991"},{"key":"2026070905575550700_LUNDGREN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Lundgren\n            E\n          , Rastad J, Thurfjell E, Akerstrom G & Ljunghall S 1997 Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery121287\u2013294.","DOI":"10.1016\/S0039-6060(97)90357-3"},{"key":"2026070905575550700_MATTSSON-AND-WALLGREN-1984","doi-asserted-by":"crossref","unstructured":"Mattsson\n            B\n           & Wallgren A 1984 Completeness of the Swedish cancer register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiologica Oncology23305\u2013313.","DOI":"10.3109\/02841868409136026"},{"key":"2026070905575550700_MICHELS-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Michels\n            KB\n          , Xue F, Brandt L & Ekbom A 2004 Hyperparathyroidism and subsequent incidence of breast cancer. International Journal of Cancer110449\u2013451.","DOI":"10.1002\/ijc.20155"},{"key":"2026070905575550700_NILSSON-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Nilsson\n            IL\n          , Wadsten C, Brandt L, Rastad J & Ekbom A 2004 Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery5981\u2013987.","DOI":"10.1016\/j.surg.2004.05.044"},{"key":"2026070905575550700_PALMER-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Palmer\n            M\n          , Ljunghall S, Akerstrom G, Adami HO, Bergstrom R, Grimelius L, Rudberg C & Johansson H 1987 Patients with primary hyperparathyroidism operated on over a 24-year period: temporal trends of clinical and laboratory findings. Journal of Chronic Diseases40121\u2013130.","DOI":"10.1016\/0021-9681(87)90063-4"},{"key":"2026070905575550700_PALMER-ETAL-1988","doi-asserted-by":"crossref","unstructured":"Palmer\n            M\n          , Adami HO, Krusemo UB & Ljunghall S 1988 Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study. American Journal of Epidemiology1271031\u20131040.","DOI":"10.1093\/oxfordjournals.aje.a114879"},{"key":"2026070905575550700_PICKARD-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Pickard\n            AL\n          , Gridley G, Mellemkj\u00e6 L, Johansen C, Kofoed-Enevoldsen A, Cantor K & Brinton L 2002 Hyperparathyroidism and subsequent cancer risk in Denmark. Cancer951611\u20131617.","DOI":"10.1002\/cncr.10846"},{"key":"2026070905575550700_SAMAAN-ETAL-1976","unstructured":"Samaan\n            NA\n          , Hickey RC, Sethi MR, Yang KP & Wallace S 1976 Hypercalcemia in patients with known malignent disease. Surgery80382\u2013389."},{"key":"2026070905575550700_SKOGSEID-2003","doi-asserted-by":"crossref","unstructured":"Skogseid\n            B\n          \n          2003 Multiple endocrine neoplasia type 1. British Journal of Surgery90383\u2013385.","DOI":"10.1002\/bjs.4110"},{"key":"2026070905575550700_SOREIDE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Soreide\n            JA\n          , van Heerden JA, Grant CS, Yau Lo C, Schleck C & Ilstrup DM 1997 Survival after surgical treatment for primary hyperparathyroidism. Surgery1221117\u20131123.","DOI":"10.1016\/S0039-6060(97)90216-6"},{"key":"2026070905575550700_VALDEMARSSON-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Valdemarsson\n            S\n          , Lindergard B, Tibblin S & Bergenfelz A 1998 Increased biochemical markers of bone formation and resorption in primary hyperparathyroidism with special reference to patients with mild disease. Journal of Internal Medicine243115\u2013122.","DOI":"10.1046\/j.1365-2796.1998.00241.x"},{"key":"2026070905575550700_WERMERS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Wermers\n            RA\n          , Khosla S, Atkinson E, Grant C, Hodgson S, O\u2019Fallon M & Melton J 1998 Survival after the diagnosis of hyperparathyroidism: a population-based study. American Journal of Medicine104115\u2013122.","DOI":"10.1016\/S0002-9343(97)00270-2"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/14\/1\/0140135.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/1\/135\/150029\/0140135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/14\/1\/135\/150029\/0140135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:58:06Z","timestamp":1783591086000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/14\/1\/135\/26702\/The-association-between-primary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.01261","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3,1]]}}}